re.Mind Capital is a specialist venture capital fund dedicated to mental health, neurological health, brain-computer interfaces, digital health, and new pharma. It is the mental health VC arm of entrepreneur Christian Angermayer and his family office, Apeiron Investment Group.
60% of their portfolio is in Healthcare. Their most common stage is series-a (40% of deals). Average disclosed round size is $65.9M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
MD
Max de Vere
Co-founder and partner
JH
Jan Hardorp
Partner
JB
Joao Barbosa da Silva
Investor
KJ
Katherine Jones
Investor
CA
Christian Angermayer
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Anna Health | Unknown | $9.3M | Nov 2024 |
 Motif Neurotech | Series A | $18.8M | Jan 2024 |
| Anna Health | Unknown | $9.3M | Jan 2024 |
 Precision | Series B | $41M | Jan 2023 |
 Sensorium Therapeutics | Series A | $30M | Nov 2022 |
 iLoF | Seed | — | Jul 2022 |
 Neumora Therapeutics, Inc. | Series A | — | Oct 2021 |
 Blackrock Neurotech | Seed | $10M | May 2021 |
 Anna | Unknown | $9.3M | — |
| Neumora Therapeutics, Inc. | Series A | $400M | — |
Top Co-Investors
GreyMatter Capital3 shared
Virtue3 shared
Watershed Ventures3 shared
Mubadala Ventures2 shared
Dolby Family Ventures2 shared
Catalio Capital Management2 shared
F-Prime Capital2 shared
Alexandria Venture Investments2 shared
Logos Capital2 shared
Surveyor Capital2 shared
Altitude Life Science Ventures2 shared
ARCH Venture Partners2 shared
Polaris Partners2 shared
Newpath Partners2 shared
The Invus Group, LLC2 shared
Alter Global1 shared
M121 shared
Scale Venture Partners1 shared
Quiet Capital1 shared
Berggruen Holdings1 shared
Last updated: 20 October 2026